Vanguard reports 0 shares beneficially owned in RxSight
RxSight Inc disclosure: The Vanguard Group filed an amended Schedule 13G/A reporting that, after an internal realignment, certain Vanguard subsidiaries will report holdings separately and The Vanguard Group no longer beneficially owns those securities.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RxSight Inc disclosure: The Vanguard Group filed an amended Schedule 13G/A reporting that, after an internal realignment, certain Vanguard subsidiaries will report holdings separately and The Vanguard Group no longer beneficially owns those securities. The filing states amount beneficially owned: 0 shares representing 0% of the class.
The amendment explains the disaggregation is in accordance with SEC Release No. 34-39538 and is signed by Ashley Grim, Head of Global Fund Administration.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RXST Schedule 13G/A amendment report about Vanguard's holdings?
Does the RXST filing say Vanguard still controls any voting or dispositive power?
Who signed the RXST amendment and when was it signed?
Why are Vanguard subsidiaries reporting separately in the RXST filing?
Does the RXST amendment identify any third party with rights to dividends or proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.